|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Harvard Accelerator Program, Proving Its Mettle with Startups and Pharma Partnerships, Looks to Raise Big New Fund
|
Gregory T. Huang |
08/11/11 |
Boston
|
|
Foundation Medicine Teams With Celgene in Quest to Develop Targeted Cancer Treatments
|
Arlene Weintraub |
05/17/11 |
New York
|
|
Novartis Edges Out Biogen Idec in Oral MS Drug Race, Ironwood Sells Microbia to DSM, RXi Teams With Eyegate, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
09/24/10 |
Boston
|
|
Zalicus, Formerly the Bicoastal Biotech CombinatoRx, Seeks New Identity with Name Fit for a Warrior
|
Ryan McBride |
09/20/10 |
Boston
|
|
Ironwood Drug Passes Clinical Test, Genzyme Cuts Jobs and Sheds Business Unit, Third Rock Closes $426M Fund, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
09/17/10 |
Boston
|
|
Third Rock Ventures Secures $426M Second Fund, Makes Changes to Partner Ranks
|
Ryan McBride |
09/13/10 |
Boston
|
|
Pfizer Axes Celldex Agreement, Vertex’s Telaprevir Performs in Clinical Trial, Anchor Therapeutics Inks Potential $480M Deal With J&J, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
09/10/10 |
Boston
|
|
CombinatoRx Becomes Zalicus
|
Erin Kutz |
09/09/10 |
Boston
|
|
Oracle Acquires Phase Forward, Diax Collects Up to $12M from Paul Capital, Agios Gets $130M from Celgene, & More Boston-Area Deals News
|
Erin Kutz |
04/21/10 |
Boston
|
|
Genzyme Activist Joins Board, Agios Clinches Deal With Celgene, Third Rock Seeks $400M New Fund, & More Boston-Area Life Sciences News
|
Erin Kutz |
04/16/10 |
Boston
|
|
Foundation Medicine Raises $25M to Get to the Bottom of Cancer Genomes
|
Ryan McBride |
04/14/10 |
Boston
|
|
Avila Sets Out to Take on Vertex, CombinatoRx Nails FDA Approval, Millipore Opts for Merck KGaA over Thermo Fisher, & More Boston-Area Life Sciences News
|
Erin Kutz |
03/05/10 |
Boston
|
|
CombinatoRx Grabs $40M with FDA Approval
|
Ryan McBride |
03/02/10 |
Boston
|
|
Zafgen Plans Weight-Loss Study, Infinity CEO Perkins Plans for Growth, Boston Scientific Cuts 1000+ Jobs, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
02/12/10 |
Boston
|
|
Former CombinatoRx CEO Alexis Borisy Lands at Third Rock Ventures, Launches New Startup
|
Ryan McBride |
02/11/10 |
Boston
|
|
CombinatoRx Names New CEO
|
Luke Timmerman |
01/06/10 |
Boston
|
|
The Boston Biotech Survival Index: Big Fish Still Swimming, Minnows Getting Eaten
|
Luke Timmerman |
10/08/09 |
Boston
|
|
Boston-Area Tech Layoffs Slow: A Recap of Summer’s Job Cuts at Analog Devices, CombinatoRx, and Other Firms
|
Ryan McBride |
08/17/09 |
Boston
|
|
VMware Springs for SpringSource, Turbine Takes $6.7M, CombinatoRx Teams With Clinical Data, & More Boston-Area Deals News
|
Rebecca Zacks |
08/14/09 |
Boston
|
|
$252M Potential in CLDA and CombinatoRx Deal
|
Ryan McBride |
08/13/09 |
Boston
|
|
Biogen Idec Buys MS Drug Rights, Immuneering Models Cancer Drug Responses, Hologic Wins Contraceptive Device Approval, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
07/08/09 |
Boston
|
|
Former CEO Alexis Borisy Voices Mixed Feelings on CombinatoRx Saga
|
Ryan McBride |
07/06/09 |
Boston
|
|
LogMeIn Pulls Off a $107 million IPO, CombinatoRx To Pair With Neuromed, CloudSwitch Turns on $8M, & More Boston-Area Deals News
|
Rebecca Zacks |
07/06/09 |
Boston
|
|
CombinatoRx to Combine with Neuromed, CEO Borisy Steps Down
|
Ryan McBride |
07/01/09 |
Boston
|
|
Genentech Veteran Takes Agios’ Helm, E8 and MIT Take on Navigenics, Genzyme’s Mipomersen Takes Next Step, Alnylam Takes Advantage of Tekmira Technology, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
05/28/09 |
Boston
|
|
CombinatoRx Diabetes Drug Shows Promise
|
Ryan McBride |
05/27/09 |
Boston
|
|
Battery Ventures Backs ExactTarget, $22M for Tokai Pharmaceuticals, Ironwood Banks $40M in European Deal, & Much Much More Boston-Area Deals News
|
Rebecca Zacks |
05/11/09 |
Boston
|
|
Ironwood Inks $40M Deal with Laboratorios Almirall, CombinatoRx and Novartis Seek Combo Cancer Drugs, NABsys Nabs $4M, & More Boston-Area Life Sciences Deals
|
Rebecca Zacks |
05/07/09 |
Boston
|
|
CombinatoRx Cuts Deal for Cancer Drug Discovery with Novartis
|
Ryan McBride |
05/06/09 |
Boston
|
|
Biotech Survival Index 2: Boston Life Sciences Companies Squirrel Away More Cash for Long Winter
|
Luke Timmerman |
03/17/09 |
Boston
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.